H62N (p.His62Asn) variant of TNXB (Tenascin-X)
H62N (p.His62Asn) in TNXB (Tenascin-X) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.81 / 1. The record also includes structural context.
H62N (p.His62Asn) variant details
- p.His62Asn
- NCI-TCGA Cosmic COSV1009
- cosmic curated COSV10092
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.805
- ESM-1b 1.00
- AlphaMissense 0.57
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available